BCTXL Stock Summary and Trading Ideas (Briacell Therapeutics Corp. - Warrants | NASDAQ:BCTXL)

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Briacell Therapeutics Corp. - Warrants trades on the NASDAQ stock market under the symbol BCTXL.

As of September 4, 2026, BCTXL stock price was flat at $0.94 with million shares trading.

BCTXL has a market cap of $0.00. This is considered a Sub-Micro Cap stock.

BCTXL support price is $.85 and resistance is $1.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCTXL shares will trade within this expected range on the day.